Drug class
First-generation tricyclic H1 antihistamine; antiallergic agent
Mechanism of action
Antagonises histamine H1 receptors, reducing allergic symptoms such as itching, urticaria and rhinitis. It can produce sedative and anticholinergic effects.
General use cases
- Symptomatic treatment of allergic disorders including urticaria, allergic rhinitis and pruritic dermatoses in countries where bisulepin products are authorised; availability is jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
